logo
  

FedEx To Increase Shipping Rates Effective January 1, 2018

FedEx Corp. (FDX) said that its subsidiaries FedEx Express, FedEx Ground and FedEx Freight will increase shipping rates effective January 1, 2018.

FedEx Express will increase shipping rates by an average of 4.9% for U.S. domestic, U.S. export and U.S. import services. FedEx One Rate pricing will increase by an average of 3.5%.

FedEx Ground and FedEx Home Delivery shipping rates will increase by an average of 4.9%. FedEx SmartPost rates will also change.

FedEx Freight shipping rates will increase by an average of 4.9%. This rate change applies to eligible FedEx Freight shipments within the U.S. (including Alaska, Hawaii, Puerto Rico and the U.S. Virgin Islands), between the contiguous U.S. and Canada, within Canada and between the contiguous U.S. and Mexico. FedEx Freight rates within Mexico will also change.

Effective January 22, 2018, a Third Party Billing Surcharge will apply to FedEx Express and FedEx Ground shipments that are billed to a third party.

Effective January 22, 2018, applicable criteria and pricing for packages that require additional handling, are oversized, or are unauthorized, will change.

Effective January 22, 2018, FedEx SmartPost will apply dimensional weight pricing, and the Non-Machinable Surcharge will change.

Effective January 22, 2018, FedEx Freight will implement an Over Length Surcharge of $85 per shipment and will be applied to shipments with dimensions of 8 feet or greater and less than 12 feet.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT